focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,144.00
Bid: 12,140.00
Ask: 12,144.00
Change: -22.00 (-0.18%)
Spread: 4.00 (0.033%)
Open: 12,186.00
High: 12,198.00
Low: 12,114.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks turn red on return from Easter break

Tue, 02nd Apr 2024 15:22

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

The FTSE 100 ended the day down 0.22% at 7,935.09, while the FTSE 250 fell 0.86% to finish at 19,713.89.

In currency markets, sterling was last up 0.16% on the dollar to trade at $1.2572, while it declined 0.05% against the euro, changing hands at €1.1677.

"The UK stock market continued where it left off before the Easter break and briefly made a new 14-month high above the 8,000 mark despite disappointing UK house price data before ending the day flat," said IG senior market analyst Axel Rudolph.

"Other European stock indices were trading lower, in line with their US counterparts, despite German inflation dropping to a near three-year low and euro area inflation expectations hitting a two-year low.

"Monday's stronger-than-expected US ISM factory activity and a rebound in new orders for manufacturing goods in Europe and the US led to US yields nearing three-month highs."

Rudolph said they did so amid worries that inflation could return, provoking a sell-off in equities following their strong first-quarter rally.

"While the gold price hit a new record high on Tuesday, with the silver price playing catch up and nearing its December and March peaks, the oil price remains on track for its fourth straight day of gains amid heightened geopolitical tensions in the Middle East."

Manufacturing sector expands, house price growth slows

In economic news, the UK manufacturing sector saw a welcome expansion last month, marking the first growth since July 2022.

According to a closely-followed survey by S&P Global, the purchasing managers' index (PMI) for the manufacturing sector climbed from 47.5 in February to 50.3 in March.

The uptick, surpassing economists' expectations of a stagnant reading at 49.9, signified a shift towards growth.

While subindices such as new orders and output showed improvement, concerns lingered as employment and stocks of purchases continued to decline, albeit at slower rates compared to the previous month.

"Potential blockers remain such as continued weak export performance and supply chain stresses, with the neighbouring EU market the main drag on overseas demand and the Red Sea crisis still impacting supply chains," said S&P Global Market Intelligence director Rob Dobson.

"Signs from the survey that the impact of both of these factors is easing is therefore welcome news."

In contrast, the UK housing market experienced an unexpected slowdown in house price inflation.

According to data from lender Nationwide, house prices recorded a slight month-on-month decrease of 0.2% in March, following a 0.7% increase in February.

On an annual basis, prices rose 1.6%, falling short of the consensus forecast of 2.4%.

Regional disparities were evident, with Northern Ireland leading in price gains while the South West witnessed a decline.

"The small fall in the Nationwide house price index in March follows two strong months, so it's just a blip," said Pantheon Macroeconomics chief UK economist Rob Wood.

"We continue to expect house prices to rise 4% year-over-year in 2024, broadly in line with the current trend pace of increase in the main house price indices but a little weaker than the rise in nominal wages we expect as affordability is stretched."

On the continent, eurozone manufacturing activity faced headwinds in March as demand dwindled.

The final HCOB eurozone manufacturing PMI slipped to 46.1 from February's 46.5, indicating contraction for the month.

Despite that, there was a slight uptick in the PMI output index, hinting at a modest improvement in output levels.

Across the Atlantic, the US labour market showed signs of stability, with job openings remaining largely unchanged in February.

According to the Department of Labor, the number of job openings increased marginally by 0.1% from the prior month to reach 8.756 million.

Hiring also saw a modest uptick, while the quits rate and total separations remained relatively stable.

Commodities lift miners and oil plays, consumer stocks slip

On London's equity markets, mining and oil stocks were buoyed by an uptick in commodity prices.

Fresnillo led the risers with a gain of 7.58%, followed by Anglo American, up 4.6%; Rio Tinto, ahead 1.99%; Glencore, which added 3.01%; BP, advancing 2.74%; Antofagasta, which grew 1.32%; and Shell, which closed 3.22% firmer.

Elsewhere, HSBC Holdings saw a modest rise of 0.39% after completing the sale of its Canadian banking operations to RBC.

The move was expected to unlock significant value, with the company expecting to recognize a gain on sale of $4.9bn in the first quarter of 2024.

On the downside, consumer goods companies faced headwinds, with Reckitt Benckiser Group down 4.15%, Coca-Cola HBC off 2.2%, and Ocado Group closing 4.22% weaker.

Housebuilders also struggled, with Persimmon off 3.5% and Taylor Wimpey losing 3.06%, and builders' merchant CRH sliding 2.4% on the back of the weak housing price data.

Real estate developers Land Securities Group, Segro, Hammerson and Unite Group also found themselves in the red, losing 0.33%, 0.35%, 3.53% and 3.27%, respectively.

Biopharma giant AstraZeneca slipped 0.69% despite receiving approval from US regulators for its Voydeva drug.

Meanwhile, Ithaca Energy slumped 7.97% following last week's reports of potential tie-ups with Italy's Eni and disappointing annual profits blamed on government energy taxes.

Additionally, Mobico Group continued its downward trend, losing 5.39% a week after issuing a profit warning and facing delays in its annual results due to auditing issues.

Reporting by Josh White for Sharecast.com.

Market Movers

FTSE 100 (UKX) 7,935.09 -0.22%

FTSE 250 (MCX) 19,713.89 -0.86%

techMARK (TASX) 4,478.92 -1.28%

FTSE 100 - Risers

Fresnillo (FRES) 504.00p 7.58%

Anglo American (AAL) 2,041.50p 4.60%

Shell (SHEL) 2,717.00p 3.50%

Glencore (GLEN) 448.40p 3.01%

BP (BP.) 508.60p 2.60%

Convatec Group (CTEC) 293.40p 2.44%

Rio Tinto (RIO) 5,117.00p 1.99%

Antofagasta (ANTO) 2,066.00p 1.32%

United Utilities Group (UU.) 1,041.00p 1.17%

Beazley (BEZ) 673.00p 1.13%

FTSE 100 - Fallers

Reckitt Benckiser Group (RKT) 4,275.00p -5.25%

Entain (ENT) 757.60p -4.99%

Ocado Group (OCDO) 435.90p -4.22%

Persimmon (PSN) 1,270.00p -3.50%

Burberry Group (BRBY) 1,171.50p -3.42%

Unite Group (UTG) 946.00p -3.27%

M&G (MNG) 213.30p -3.27%

Bunzl (BNZL) 2,950.00p -3.22%

Land Securities Group (LAND) 637.50p -3.14%

Scottish Mortgage Inv Trust (SMT) 867.60p -3.13%

FTSE 250 - Risers

AO World (AO.) 104.20p 3.37%

Kainos Group (KNOS) 994.00p 2.95%

TI Fluid Systems (TIFS) 148.20p 2.92%

Fidelity China Special Situations (FCSS) 206.50p 2.74%

Dr. Martens (DOCS) 90.05p 2.62%

Petershill Partners (PHLL) 194.00p 2.54%

Renishaw (RSW) 4,350.00p 2.35%

Bakkavor Group (BAKK) 110.50p 2.31%

BlackRock World Mining Trust (BRWM) 529.00p 2.13%

Diversified Energy Company (DEC) 967.50p 2.06%

FTSE 250 - Fallers

Ithaca Energy (ITH) 122.40p -7.97%

Mobico Group (MCG) 64.50p -7.33%

Tritax Eurobox (GBP) (EBOX) 50.90p -6.26%

Carnival (CCL) 1,102.50p -5.73%

Watches of Switzerland Group (WOSG) 340.80p -4.96%

Aston Martin Lagonda Global Holdings (AML) 161.80p -4.77%

Trustpilot Group (TRST) 189.40p -4.73%

Marshalls (MSLH) 263.00p -4.29%

Oxford Instruments (OXIG) 2,040.00p -4.00%

Close Brothers Group (CBG) 402.20p -3.83%

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.